156 related articles for article (PubMed ID: 12466030)
1. Pilot-controlled trial of D-cycloserine for the treatment of post-traumatic stress disorder.
Heresco-Levy U; Kremer I; Javitt DC; Goichman R; Reshef A; Blanaru M; Cohen T
Int J Neuropsychopharmacol; 2002 Dec; 5(4):301-7. PubMed ID: 12466030
[TBL] [Abstract][Full Text] [Related]
2. Pilot controlled trial of D-serine for the treatment of post-traumatic stress disorder.
Heresco-Levy U; Vass A; Bloch B; Wolosker H; Dumin E; Balan L; Deutsch L; Kremer I
Int J Neuropsychopharmacol; 2009 Oct; 12(9):1275-82. PubMed ID: 19366490
[TBL] [Abstract][Full Text] [Related]
3. The Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST): the efficacy of glutamatergic agents for negative symptoms and cognitive impairments.
Buchanan RW; Javitt DC; Marder SR; Schooler NR; Gold JM; McMahon RP; Heresco-Levy U; Carpenter WT
Am J Psychiatry; 2007 Oct; 164(10):1593-602. PubMed ID: 17898352
[TBL] [Abstract][Full Text] [Related]
4. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.
Tsai GE; Falk WE; Gunther J; Coyle JT
Am J Psychiatry; 1999 Mar; 156(3):467-9. PubMed ID: 10080566
[TBL] [Abstract][Full Text] [Related]
5. D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
Difede J; Cukor J; Wyka K; Olden M; Hoffman H; Lee FS; Altemus M
Neuropsychopharmacology; 2014 Apr; 39(5):1052-8. PubMed ID: 24217129
[TBL] [Abstract][Full Text] [Related]
6. Randomized placebo-controlled D-cycloserine with cognitive behavior therapy for pediatric posttraumatic stress.
Scheeringa MS; Weems CF
J Child Adolesc Psychopharmacol; 2014 Mar; 24(2):69-77. PubMed ID: 24506079
[TBL] [Abstract][Full Text] [Related]
7. A randomized placebo-controlled trial of D-cycloserine and exposure therapy for posttraumatic stress disorder.
Litz BT; Salters-Pedneault K; Steenkamp MM; Hermos JA; Bryant RA; Otto MW; Hofmann SG
J Psychiatr Res; 2012 Sep; 46(9):1184-90. PubMed ID: 22694905
[TBL] [Abstract][Full Text] [Related]
8. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
[TBL] [Abstract][Full Text] [Related]
9. D-cycloserine increases positive symptoms in chronic schizophrenic patients when administered in addition to antipsychotics: a double-blind, parallel, placebo-controlled study.
van Berckel BN; Evenblij CN; van Loon BJ; Maas MF; van der Geld MA; Wynne HJ; van Ree JM; Kahn RS
Neuropsychopharmacology; 1999 Aug; 21(2):203-10. PubMed ID: 10432468
[TBL] [Abstract][Full Text] [Related]
10. Controlled trial of D-cycloserine adjuvant therapy for treatment-resistant major depressive disorder.
Heresco-Levy U; Javitt DC; Gelfin Y; Gorelik E; Bar M; Blanaru M; Kremer I
J Affect Disord; 2006 Jul; 93(1-3):239-43. PubMed ID: 16677714
[TBL] [Abstract][Full Text] [Related]
11. A preliminary study of D-cycloserine treatment in Alzheimer's disease.
Tsai GE; Falk WE; Gunther J
J Neuropsychiatry Clin Neurosci; 1998; 10(2):224-6. PubMed ID: 9608414
[TBL] [Abstract][Full Text] [Related]
12. A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia.
Goff DC; Tsai G; Levitt J; Amico E; Manoach D; Schoenfeld DA; Hayden DL; McCarley R; Coyle JT
Arch Gen Psychiatry; 1999 Jan; 56(1):21-7. PubMed ID: 9892252
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
[TBL] [Abstract][Full Text] [Related]
14. Cognitive enhancers as adjuncts to psychotherapy: use of D-cycloserine in phobic individuals to facilitate extinction of fear.
Ressler KJ; Rothbaum BO; Tannenbaum L; Anderson P; Graap K; Zimand E; Hodges L; Davis M
Arch Gen Psychiatry; 2004 Nov; 61(11):1136-44. PubMed ID: 15520361
[TBL] [Abstract][Full Text] [Related]
15. Augmenting transcranial direct current stimulation with (D)-cycloserine for depression: a pilot study.
Chan HN; Alonzo A; Martin DM; Mitchell PB; Sachdev P; Loo CK
J ECT; 2013 Sep; 29(3):196-200. PubMed ID: 23792778
[TBL] [Abstract][Full Text] [Related]
16. Baclofen treatment for chronic posttraumatic stress disorder.
Drake RG; Davis LL; Cates ME; Jewell ME; Ambrose SM; Lowe JS
Ann Pharmacother; 2003 Sep; 37(9):1177-81. PubMed ID: 12921495
[TBL] [Abstract][Full Text] [Related]
17. D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder.
Storch EA; Merlo LJ; Bengtson M; Murphy TK; Lewis MH; Yang MC; Jacob ML; Larson M; Hirsh A; Fernandez M; Geffken GR; Goodman WK
Int Clin Psychopharmacol; 2007 Jul; 22(4):230-7. PubMed ID: 17519647
[TBL] [Abstract][Full Text] [Related]
18. D-cycloserine for the treatment of ataxia in spinocerebellar degeneration.
Ogawa M; Shigeto H; Yamamoto T; Oya Y; Wada K; Nishikawa T; Kawai M
J Neurol Sci; 2003 Jun; 210(1-2):53-6. PubMed ID: 12736088
[TBL] [Abstract][Full Text] [Related]
19. A Meta-Analysis of D-Cycloserine in Exposure-Based Treatment: Moderators of Treatment Efficacy, Response, and Diagnostic Remission.
McGuire JF; Wu MS; Piacentini J; McCracken JT; Storch EA
J Clin Psychiatry; 2017 Feb; 78(2):196-206. PubMed ID: 27314661
[TBL] [Abstract][Full Text] [Related]
20. The partial NMDA agonist D-cycloserine stimulates LH secretion in healthy volunteers.
van Berckel BN; Lipsch C; Gispen-de Wied C; Wynne HJ; Blankenstein MA; van Ree JM; Kahn RS
Psychopharmacology (Berl); 1998 Jul; 138(2):190-7. PubMed ID: 9718289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
